Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – At one of the first sessions of this conference of infectious diseases physicians, scientists discussed an urgent need to scale up tuberculosis prevention efforts globally, especially in light of data expected from the World Health […]
NIH Director Collins, in turn, says 10 percent apportioned to HIV for last two decades won’t be automatic “As a practicing physician, sometimes still,” Sen. William Cassidy (R – La), told National Institutes of Health Director Dr. Francis Collins today during an Appropriations sub-committee hearing on funding for the agency, “I think we should double your […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]